Company
About the CEO
Achieve in advance what others cannot do!
Greetings from the CEO,
I sincerely appreciate your cheering supports and interest in EncuraGen.
EncuraGen is engaged in scientific research to find fundamental cures through the physiological homeostasis for the patients suffering from various hard-to-cure diseases, not just alleviating symptoms. EncuraGen is dedicated to the research/development of innovative medicines to offer comprehensive therapeutics for cure and care. Moreover, we are also a specialized, dedicated R&D company engaged in in synthetic biology, which will offer a new horizon to prospective industries, on the basis of the broad, creative implementation of basic life sciences
All the executives and employees are endeavoring to make EncuraGen a company that challenges the world beyond Korea. We promise that the accomplishments of our efforts will deliver various results that ultimately contribute to the well-being of human and society. EncuraGen will keep in mind that people are the fundamental of all value creation and will do our best to consistently advance and pursue it.
CEO Brian Kim, Ph.D.
CEO Brian Kim, Ph.D.
Dr. Brian Kim has gained experience and made achievements in the development and approval of innovative new drugs in many countries as a key executive in the fields of R&D, quality management, regulatory affairs in multinational pharmaceutical companies such as Pfizer, Allergan, Genentech (formerly known as Tanox) in the USA as well as Celltrion in Korea. Furthermore, he is an expert in biomedicine with extensive experience in the development and approvals of various new biotechnological products, including the world’s first antibody biosimilar of Herceptin® and Ramicade®.